These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 8904249)
21. Nature and role of proteasomes in maturation of fish oocytes. Tokumoto T Int Rev Cytol; 1999; 186():261-94. PubMed ID: 9770302 [TBL] [Abstract][Full Text] [Related]
22. Proteasome and cell cycle. Evidence for a regulatory role of the protease on mitotic cyclins in yeast. Richter-Ruoff B; Wolf DH FEBS Lett; 1993 Dec; 336(1):34-6. PubMed ID: 8262212 [TBL] [Abstract][Full Text] [Related]
24. Involvement of the ubiquitin-proteasome pathway in the degradation of nontyrosine kinase-type cytokine receptors of IL-9, IL-2, and erythropoietin. Yen CH; Yang YC; Ruscetti SK; Kirken RA; Dai RM; Li CC J Immunol; 2000 Dec; 165(11):6372-80. PubMed ID: 11086075 [TBL] [Abstract][Full Text] [Related]
25. [Regulation of cell division by ubiquitin-dependent proteolysis and spindle assembly checkpoint]. Kazuo T Tanpakushitsu Kakusan Koso; 1999 Mar; 44(3):253-62. PubMed ID: 10097657 [No Abstract] [Full Text] [Related]
26. [Molecular mechanism of carcinogenesis in human stomach cancer: Bub1 gene]. Inaba T; Maesawa C; Masuda T; Terashima M Nihon Rinsho; 2001 Apr; 59 Suppl 4():44-7. PubMed ID: 11424422 [No Abstract] [Full Text] [Related]
27. Can impaired proteasome function cause aneuploidy? Wojcik C Trends Cell Biol; 2001 Jun; 11(6):241. PubMed ID: 11356349 [No Abstract] [Full Text] [Related]
28. The ubiquitin-proteasome pathway in distal myopathy with rimmed vacuoles. Jimi T; Wakayama Y Intern Med; 1998 Sep; 37(9):722-3. PubMed ID: 9804076 [No Abstract] [Full Text] [Related]
30. Involvement of the proteasome in various degradative processes in mammalian cells. Matthews W; Driscoll J; Tanaka K; Ichihara A; Goldberg AL Proc Natl Acad Sci U S A; 1989 Apr; 86(8):2597-601. PubMed ID: 2539595 [TBL] [Abstract][Full Text] [Related]
31. Are there multiple proteolytic pathways contributing to c-Fos, c-Jun and p53 protein degradation in vivo? Salvat C; Aquaviva C; Jariel-Encontre I; Ferrara P; Pariat M; Steff AM; Carillo S; Piechaczyk M Mol Biol Rep; 1999 Apr; 26(1-2):45-51. PubMed ID: 10363646 [TBL] [Abstract][Full Text] [Related]
32. Proteasomes: protein degradation machines of the cell. Peters JM Trends Biochem Sci; 1994 Sep; 19(9):377-82. PubMed ID: 7985232 [TBL] [Abstract][Full Text] [Related]
33. Ubiquitin proteasome pathway: implications and advances in cancer therapy. Shah SA; Potter MW; Callery MP Surg Oncol; 2001; 10(1-2):43-52. PubMed ID: 11719028 [TBL] [Abstract][Full Text] [Related]
34. Ubiquitin-proteasome system and proteasome inhibition: new strategies in stroke therapy. Wojcik C; Di Napoli M Stroke; 2004 Jun; 35(6):1506-18. PubMed ID: 15118168 [TBL] [Abstract][Full Text] [Related]
35. Proteasome-dependent degradation of human CDC25B phosphatase. Cans C; Ducommun B; Baldin V Mol Biol Rep; 1999 Apr; 26(1-2):53-7. PubMed ID: 10363647 [TBL] [Abstract][Full Text] [Related]
37. Ubiquitin, E6-AP, and their role in p53 inactivation. Scheffner M Pharmacol Ther; 1998 Jun; 78(3):129-39. PubMed ID: 9690814 [TBL] [Abstract][Full Text] [Related]
38. Eponemycin exerts its antitumor effect through the inhibition of proteasome function. Meng L; Kwok BH; Sin N; Crews CM Cancer Res; 1999 Jun; 59(12):2798-801. PubMed ID: 10383134 [TBL] [Abstract][Full Text] [Related]
39. A role for the proteasome in HIV infection. Perks B Trends Immunol; 2001 Jan; 22(1):12. PubMed ID: 11286680 [No Abstract] [Full Text] [Related]